Pricing Log in Create free account

Cytosorbents Corporation (CTSO) vs Vicarious Surgical Inc. (RBOT)

Cytosorbents Corporation and Vicarious Surgical Inc. are both Medical Devices companies. Cytosorbents Corporation and Vicarious Surgical Inc. are of similar size ($14.5M and $14.3M). Vicarious Surgical Inc. has the higher net margin (0.00% vs −48.9%) and the higher return on invested capital (0.00% vs −66.9%). Across the 13 metrics below, Vicarious Surgical Inc. leads on 8 and Cytosorbents Corporation on 5.

Valuation

Metric CTSO RBOT Medical Devices median
P/E n/m n/m 24.94
P/S 0.40 n/m 2.66
P/B n/m n/m 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA n/m 0.08 11.42
EV/Sales 0.75 n/m 2.76
Earnings yield (122.11%) 0.00% (12.66%)
Free cash flow yield (63.17%) 0.00% (7.18%)

Profitability

Metric CTSO RBOT Medical Devices median
Gross margin 71.61% 0.00% 57.76%
Operating margin (34.74%) 0.00% (14.84%)
Net margin (48.94%) 0.00% (14.45%)
Free cash flow margin (25.32%) 0.00% (5.70%)
Return on equity (336.17%) (223.75%) (10.56%)
Return on assets (42.38%) (124.54%) (17.26%)
Return on invested capital (66.90%) 0.00% (5.22%)

Growth

Metric CTSO RBOT Medical Devices median
Revenue growth (TTM) 3.07% — 10.41%
EPS growth (last fiscal year) 65.79% 23.74% 28.17%
Revenue growth, 5-year CAGR (2.00%) — 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTSO RBOT Medical Devices median
Debt to equity (22.96) 0.00 0.04
Current ratio 0.66 1.54 2.67
Net debt to EBITDA (0.85) 0.20 0.54

Dividend

Metric CTSO RBOT Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric CTSO RBOT Medical Devices median
Market cap 14.50m 14.31m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack